Skip to main content

Join our Webinars

Find out about the latest breakthroughs in clinical diagnostics and get valuable insights from international healthcare experts. With the goal of improving patient management in critical care settings, we have created a series of webinars that look at the latests diagnostic innovations and how they influence the clinical practice today. 

Upcoming Webinars:


Personalized medicine in critical care – The potential of biomarkers to enhance treatment success in COVID-19

Biomarkers are playing a key role for a successful personalized medical approach in treating severely ill patients. They allow the identification of different, sometimes competing pathophysiologies requiring different treatment strategies. In the AGNES-19 trial, enrolling moderate to severely ill COVID-19 patients, the biomarkers bio-ADM and DPP3 are guiding the application of a new drug candidate.    

Date: Thursday, June 9, 2022 | 16:00-17:00 CEST
Participation Fee: Free
Speaker: Dr. Mahir Karakas, MD, MBA; University Medical Center Hamburg-Eppendorf, Hamburg

On demand Webinars:


Using Proenkephalin as a Novel Biomarker to Estimate GFR

The standard of care to determine kidney function has significant limitations, including late detection of changes in kidney function and the influence of non-renal factors on its results. The biomarker Proenkephalin provides a solution to assess changes in kidney function earlier compared to creatinine. 

Prof. Peter Pickkers (Radboud University, Nijmegen) will present the research background alongside a new GFR formula that translates penKid concentrations into an estimated GFR for the routine clinical use initially in adults.

Participation Fee: Free
Speaker: Prof. Dr. Peter Pickkers, Radboud University, Nijmegen

Webinar Series: Use of Biomarkers in the Emergency Department


Sepsis in the Emergency Department: recognizing high-risk patients with the biomarker Bioactive Adrenomedullin

Recognizing the high risk sepsis patients at the Emergency Department (ED) poses a certain challenge, yet a timely therapeutic intervention is crucial for the patients’ survival. Find out how a novel biomarker of endothelial function bioactive adrenomedullin can support diagnostics and clinical decisions in the ED.

Participation Fee: Free
Speaker: Prof. Salvatore Di Somma, MD PhD; University La Sapienza Rome


Overcoming the limitations of Acute Kidney Injury (AKI) diagnostics in the Emergency Department: the biomarker Proenkephalin for early recognition of AKI

Acute Kidney Injury is a serious complication of multiple severe conditions such as sepsis, yet is difficult to recognize with the current standard of care diagnostics in the patients presented at the ED. The novel functional kidney biomarker Proenkephalin A can bridge the gap in timely diagnostics of AKI in the ED.

Participation Fee: Free
Speaker: Prof. Salvatore Di Somma, MD PhD; University La Sapienza Rome



Point-of-care Diagnostics in the Emergency Department: Better Patient Management

Near patient diagnostics can greatly improve the time to intervention and the outcomes for the severely sick patients presented at the ED. Learn about the possibilities of near the patient testing of well known and novel biomarkers on the point-of-care platform IB10.

Participation Fee: Free
Speaker: Prof. Salvatore Di Somma, MD PhD; University La Sapienza Rome